Burlington, North Carolina-based LabCorp is rumored to be negotiating an $8 billion acquisition of Pharmaceutical Product Development (PPD), a global contract research organization operating in over 50 countries.
INC Research’s June acquisition of Trident Clinical Research didn’t generate the same headlines among clinical research organizations as the company’s $232 million Kendle purchase. But it’s just as illustrative of what’s driving M&A trends among top clinical research organizations. Australia-based Trident has experience and expertise running clinical trials in Australia and Asia. With Trident in […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
INC Research‘s Kendle acquisition vaulted the North Carolina clinical research organization into the CRO industry’s top five and according to CEO James Ogle, helps the company become a global player. Ogle spoke with Outsourcing Pharma, a British publication that covers the CRO industry. Audio of the Outsourcing Pharma interview can be heard here. In the […]
INC Research‘s $232 million acquisition of Ohio clinical research organization Kendle (NASDAQ:KNDL) is complete. Raleigh, North Carolina-based INC announced completion of the all-cash deal Tuesday after the close of the financial markets. The combined, privately held company will operate as INC Research led by INC’s CEO James Ogle, along with his INC management team. The […]
INC Research, still completing its $232 million acquisition of clinical research organization Kendle (NASDAQ:KNDL) , has bought yet another CRO to add to its global footprint. Raleigh, North Carolina-based INC Research has acquired Australian CRO Trident Clinical Research in an aggressive move that gets INC into a fast-growing market for early phase clinical studies. Financial terms […]
INC Research‘s new CFO revealed a lofty goal for the clinical research organization shortly after joining the Raleigh, North Carolina company in February. Within five years, David Gill said, INC aims to be one of the top five CROs in the industry. Privately held INC’s $232 million acquisition of the larger Cincinnati, Ohio-based Kendle International […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
New INC Research CFO David Gill has experience taking companies public; he's guided three of them through IPOs. Gill says the Raleigh, North Carolina-based CRO is not actively looking at an IPO right now. But he adds that any private company looking to grow benefits from executive leadership with experience in public companies.
INC Research, a clinical research organization, acquires consultancy AVOS Life Sciences in a deal that adds to INC's ability to partner with pharmaceutical companies in drug development.
INC Research Inc., the contract research organization in Raleigh, North Carolina, has agreed to be acquired by private equity firm Avista Capital Partners and Ontario Teachers' Pension Plan for a reported $600 million.